Altogether, these data suggest that miR-155 and its targets Plce1, Dync1i1, Ramp3, Scl16a4, Nr1h3, Bub1b, Aldh1l1, and Nek2 are involved in the pathological immune response of muscles in DMD patients, as indicated by the overlapping genes that control the inflammatory response. This evidence concerns the gene DYNC1I1 and Duchenne muscular dystrophy.